Jubilant Pharmova Ltd.

NSE: JUBLPHARMA | BSE: 530019 | ISIN: INE700A01033 | Industry: Pharmaceuticals
| Mid-range Performer
1124.6000 -15.00 (-1.32%)
NSE Sep 11, 2025 15:31 PM
Volume: 83,940
 

logo
Jubilant Pharmova Ltd.
10 May 2018, 10:52AM
1124.60
-1.32%
buy
Results Update: Jubilant Pharmova Ltd.
by HDFC Securities
HDFC Securities
Revenue rose by 8.93% to Rs. 2223.77 Cr in Q4FY18 when compared to the previous quarter. Jubilant Life Sciences Ltd Q4FY18 results Comment
 
Jubilant Pharmova Ltd.'s price crossed below 50Day SMA today
More from Jubilant Pharmova Ltd.
Recommended
Market closes higher, Tega Industries to buy Molycop with Apollo Funds in a $1.5 bn deal
Trendlyne Marketwatch | 11 Sep 2025, 04:07PM
India’s IPO story in 2025: Investors go selective, backing quality over hype
The Baseline | 11 Sep 2025, 03:50PM
Earnings Call Transcript - Q4FY20 for Jubilant Life Sciences
| 30 May 2020